NCT Number: NCT02825693
Femtosecond Laser Assisted Cataract Surgery in The NHS
This study aims to examine the health economic impact of adopting femtosecond laser technology to assist high volume cataract surgery (FLACS) within a state-funded healthcare system, the National Health Service (NHS).
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients must have reduced visual acuity or visual symptoms attributed to the presence of cataract in one or both eyes by the examining ophthalmologist or else must require cataract surgery on clinical grounds other than visual symptoms.
- Patients must be willing to attend for follow-up at 1 month after cataract surgery.
- Patients must be sufficiently fluent in English for informed consent and self-completion of the patient reported outcome questionnaires.
Exclusion criteria
- Children below the age of 18
- Already enrolled in another study
The principle exclusion criteria relate to clinical contraindications for FLACS, such as:
- Significant corneal opacities
- Small pupils following pharmacological dilatation
- Patients unable to lie sufficiently flat so as to be positioned underneath the laser machine.
Treatment and study plan
Femtosecond laser assisted cataract surgery
ProcedurePrimary outcomes
-
Cost-analysis: Healthcare resource use attributable to managing patients in this study will be collected.
Time frame: up to 2 months
These include (but not necessarily be limited to) the cost of surgery for both arms of the trial (including resource use and staffing levels required for the surgical protocols), resource use attributable to managing complications arising from surgery, all relevant diagnostic investigations, further surgery where necessary, hospital length of stay and ward type, outpatient attendances, procedures performed on an outpatient basis, Accident & Emergency attendances and prescribed drug medications. The quantity of resource use for each cost component will be measured from medical records. Site-specific unit costs will be taken in preference of standard published sources or national tariffs where possible.
Sponsors and collaborators
Lead sponsor
Guy's and St Thomas' NHS Foundation Trust
Other
Registry information
Official study title
The Development of Surgical Pathways Using Femto-second Laser Technology to Increase the Efficiency and Safety of Cataract Surgery Within a Public Health Sector Setting - A Randomised Controlled Trial
Important dates
- Study start
- 2016
- Primary completion
- 2017
- Study completion
- 2018
- First posted
- Jul 7, 2016
- Registry last updated
- Jul 23, 2020
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Patient-preferred Aromatherapy Versus Placebo For Reducing Preoperative Anxiety In Patients Undergoing Eye Surgery
NCT07237061
Aromatherapy, Cataract
Singapore
View Trial DetailsRoutine Surgical Procedures During COVID-19 Pandemic: a French Nationwide Cohort Study
NCT05197660
COVID-19, COVID-19 Pandemic
Saint-Denis, Île-de-France Region, France
View Trial DetailsMapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
NCT01591655
Cataract, Eye Diseases
Rochester, New York, United States
View Trial DetailsMapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
NCT01591161
Cataract, Eye Diseases
Rochester, New York, United States
View Trial Details